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Abstract
Background: The leptin receptor gene (LEPR) polymorphism Q223R is one of the most common in the
general population, and is thought to be associated with an impaired signaling capacity of the leptin receptor
and with higher mean circulating levels of leptin. Leptin is a hormone primarily produced in adipose tissue.
Increased levels of leptin have been positively correlated with obesity. We have determined the frequency of
the leptin receptor polymorphism (LEPR Q223R) in healthy populations from various ethnic groups, and
compared plasma leptin levels across the LEPR  Q223R polymorphism in healthy African-Caribbean and
Caucasian women.
Results: The study population consists of 1,418 healthy subjects from various ethnic groups. The LEPR Q223R
homozygous variant was observed overall in 19% of subjects (n = 1,418), with significant differences based on
self reported ethnicity: the proportion of subjects with the homozygous variant was lower in Caucasians (14%,
n = 883) than in African-Caribbean (n = 194), African-American (n = 36) and Asian/other ethnic groups (n =
26), (35%, 33% and 34.6% respectively); the frequency in Africans (20%), was similar to the overall study
population. The mean ± standard deviation (SD), circulating leptin levels for African-Caribbean women was
44.7 ± 31.4 ng/ml, while for Caucasian women the mean was 42.4 ± 34.8 ng/ml. Adjusted circulating leptin
levels in post-menopausal Caucasian women who were LEPR Q223R homozygous variant were marginally
statistically significantly higher than in women with the wild-type genotype (p = 0.098). No significant
differences in leptin levels by genotype were observed for African-Caribbean women, (heterozygous: p =
0.765, homozygous variant: p = 0.485).
Conclusion: These findings suggest an association between mean circulating leptin levels and the LEPR Q223R
genotype among post-menopausal Caucasian women.
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Introduction
Leptin, a product of the ob gene, is a biologically active
polypeptide (16 kDa) primarily produced in adipose tis-
sue [1]. Increased levels of leptin have been shown to cor-
relate with obesity [2], a known risk factor for
postmenopausal breast cancer [3-7]. Some studies have
reported that leptin stimulates the proliferation of normal
and malignant breast epithelial cells [8] and others have
suggested that leptin levels may be associated with breast
cancer [9,10] as well as cancer at other sites [11]. Leptin
binds to the human leptin receptor, a cytokine receptor
that promotes gene transcription via activating signal
transduction pathways [12]. The function of leptin is
mediated through the leptin receptor, and both leptin and
its receptor are involved in the homeostatic control of
appetite, weight, metabolism and reproductive functions
in women [13]. A number of polymorphisms have been
reported in the human LEPR gene [14]. The LEPR poly-
morphism Q223R is one of the most common and is
thought to be associated with an impaired signaling
capacity of the leptin receptor; this polymorphism has
been associated with higher mean circulating levels of lep-
tin [15,16].
We have previously conducted a meta-analysis (n = 18
studies) to examine the frequencies of LEPR  polymor-
phisms in the general population [14]. From this analysis
of the literature, it became apparent that only one study
included subjects of African ancestry; however, this study
sample was predominantly Caucasian [17]. Although
research has been conducted on circulating leptin levels
among healthy populations of women including women
of African descent [18-24], few studies have evaluated
mean circulating leptin levels according to the LEPR
Q223R genotype [15,16,25] among healthy populations
of women. Furthermore, no previous study has evaluated
leptin levels by the LEPR Q223R polymorphism among
African-Caribbean women.
In this study, we have determined the frequency of leptin
receptor polymorphism (LEPR Q223R) in healthy popu-
lations from various ethnic groups (African, African-
American, African-Caribbean, Caucasian, Asian/and other
ethnic groups). We have also compared the LEPR Q223R
polymorphism with plasma leptin levels in healthy Afri-
can-Caribbean and Caucasian women.
Materials and methods
Study population
The study population consists of 1,418 healthy subjects
(883 Caucasians, 279 Africans, 36 African-Americans, 194
African-Caribbean, 26 Asian/other ethnic groups). Cauca-
sian subjects were recruited as part of a study on hormo-
nal determinants of mammographic density [26] as well
as a study of hormones, bone density and genetic markers
of susceptibility [27]; African-American and African sub-
jects were part of a study on ethnic differences in polymor-
phisms of genes involved in tobacco metabolism [28];
African-Caribbean subjects were recruited as part of a
study on cervical and oral HPV infection [29]. Ethnicity
for all subjects was self-reported. Nineteen of the 26 Asian
subjects were recruited from the Caribbean but self-
reported their ethnicity as East Indian.
Women had no history of hormone replacement therapy
(HRT) as determined from questionnaire data. There were
6 African-Caribbean women and one Asian who reported
ever HRT users and for 36 African-Caribbean and two
Asian women HRT use was not reported. Menopausal sta-
tus was determined by using a self reported questionnaire
on whether their menses has stopped and/or date at the
last menstrual cycle. If the date of last menstruation was
prior to six months from recruitment, women were con-
sidered post-menopausal. One subject who reported that
her menses stopped 3 months before recruitment was
included in the post-menopausal group. Twenty-nine 29
African-Caribbean women responses were missing there-
fore were unable to define their menopausal status.
Leptin levels
Nonfasting plasma leptin levels were determined for a
subpopulation of women (N = 574) using a commercially
available leptin ELISA kit (Biosource International,
Camarilli, CA, USA). Batches were performed using 96
well plates which included ~38 samples, 8 leptin stand-
ards and quality controls. Forty blinded duplicates were
included as a means of assessing the reliability of the
assay. Each sample was run in duplicate within the same
plate and a coefficient of variation (CV) was calculated.
All CV's greater than 15% were repeated. The average of
the two leptin measurements was used for this analysis.
LEPR Q223R genotyping
DNA was extracted from blood samples and the allelic fre-
quency of LEPR Q223R was evaluated for all subjects by
polymerase chain reaction (PCR) of the extracted DNA,
followed by MspI restriction enzyme digestion. The PCR
primers and cycling conditions used have been previously
published [30]. Briefly, amplification of the 80bp LEPR
PCR product was visualized following PCR amplification
and agarose gel electrophoreses. The amplified product
was then subjected to MspI restriction enzyme digestion at
37°C overnight. Samples from subjects with the wild-type
gene yielded an 80bp DNA band after MspI digestion. A
heterozygous subject sample was indicated by 80 bp, 58
bp and 22 bp PCR products while a homozygous variant
was indicated by 8 bp and 22 bp PCR products only.
Twenty samples were randomly chosen and repeated in
blind fashion to assess the reproducibility of the method.Infectious Agents and Cancer 2009, 4(Suppl 1):S13 http://www.infectagentscancer.com/content/4/S1/S13
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Statistical analysis
Statistical analyses were performed using STATA (version
SE 10.0) software (StataCorp. LP, College Station, TX).
Pearson's and the likelihood-ratio chi-squared test were
used to assess Hardy-Weinberg equilibrium. Leptin levels
were square root transformed in order to obtain a normal
distribution for parametric tests. The independent effect
of body mass index, age, menopausal status and LEPR
genotype on leptin levels by ethnic group was assessed
using a two-way analysis of variance (ANOVA).
Results
LEPR Q223R polymorphism distribution
The LEPR Q223R genotype frequency based on ethnicity
is summarized in Table 1. For the overall study popula-
tion, the frequency of the heterozygous (GA) and
homozygous (AA) variants was 50% and 18.97% respec-
tively and significant differences were observed based on
ethnicity (p < 0.0001).
Higher frequencies of the AA variant was observed among
African-Caribbean 35.1%), African-Americans (33.3%)
and Asian/Other subjects (34.6%) as compared to the
overall study population. In contrast, Caucasian subjects
had the lowest frequency of the AA variant (14.2%); the
frequency of the AA variant in Africans was similar to the
overall study population.
We observed no violation of Hardy Hardy-Weinberg equi-
librium for either the overall study population or after
stratification by ethnic groups (p > 0.1). The highest pro-
portion of subjects with the heterozygous (GA) variant
was observed in African subjects (55.7%), while Cauca-
sian subjects had the lowest frequency of the GA variant
(47.9%).
Circulating plasma leptin levels in females
Plasma leptin levels were available for 574 female subject
(149 pre-menopausal and 425 post-menopausal). These
included 340 Caucasians and 19 African-Americans post-
menopausal women, 191 African-Caribbean women
(135: pre-menopausal and 56: post-menopausal), and 24
women of Asian and other ethnic derivations (14: pre-
menopausal and 10: post-menopausal). For the entire
study population, we observed a mean circulating plasma
leptin level of 43.5 ± 33.3 ng/ml. A summary of the mean
plasma leptin levels stratified by menopausal status is
shown in Table 2. Caucasian and African-American popu-
lations consisted of post-menopausal women only, with
an overall mean circulating leptin level of 42.4 ± 34.8 ng/
ml and 61.1 ± 26.7, respectively ng/ml. Mean age was
available for all ethnic groups (African: 44.7 years, Afri-
can-American: 46.5 years, Caribbean: 41.1 years, Cauca-
sian: 50.1 years and Asian/other ethnic groups: 43.7
years), but body mass index (BMI) was not available for
the Caribbean population (African: 24.7 kg/m2, African-
American: 28.9 kg/m2, Caucasian: 26.2 kg/m2 and Asian/
other ethnic groups: 24.7 kg/m2). After adjusting the
transformed mean leptin levels for age and BMI, the mean
circulating plasma leptin level for African-Americans was
marginally statistically significantly higher than Cauca-
sians women (p = 0.07). All other ethnic groups consisted
of both pre- and post-menopausal women. African-Carib-
bean women had a mean overall plasma leptin level of
44.7 ± 31.4 ng/ml (pre-menopausal = 41.8 ± 27.8 ng/ml
vs. post-menopausal subjects = 51.7 ± 38.2 ng/ml,
adjusted transformed mean comparisons: p > 0.1). The
overall mean levels observed in African-Caribbean
women were statistically significantly higher than Cauca-
sian women after adjusting for age (p = 0.04); body mass
index data was not available for the African-Caribbean
women. For Asian and other ethnic groups, the mean
overall plasma leptin level was 35.3 ± 26.3 ng/ml (pre-
menopausal = 37.9 ± 30.4 ng/ml; post-menopausal = 31.6
± 20.0 ng/ml). After adjusting for age and BMI, the mean
transformed levels observed for post-menopausal Asian/
other women was not statistical significantly different
from that of Caucasians (p > 0.1). For pre-menopausal
women we did not observe a statistically significant differ-
ence between African-Caribbean and Asian/other ethnic
groups, after adjusting for age (p = 0.15).
Circulating leptin levels and LEPR Q223R genotype
Figure 1 shows the mean circulating leptin levels in Afri-
can-Caribbean women stratified by LEPR Q223R geno-
type. Comparisons of the transformed mean circulating
leptin levels stratified by LEPR  Q223R genotype was
accomplished after adjusting for age and menopausal sta-
tus (BMI data was not available for these subjects). For
subjects with the wild-type (GG) genotype the mean cir-
Table 1: Distribution of the LEPR Q223R genotype across ethnic groups.
LEPR Q223R African
N (%)
African-American N 
(%)
African-Caribbean N 
(%)
Caucasian N (%) Asian/Other N (%) TOTAL
N (%)
GG 69 (24.73) 6 (16.67) 26 (13.40) 335 (37.94) 4 (15.38) 440 (31.03)
GA 155 (55.56) 18 (50.00) 100 (51.55) 423 (47.90) 13 (50.00) 709 (50.00)
AA 55 (19.71) 12 (33.33) 68 (35.05) 125 (14.16) 9 (34.62) 269 (18.97)
Total 279 (100) 36 (100) 194 (100) 883 (100) 26 (100) 1,418 (100)Infectious Agents and Cancer 2009, 4(Suppl 1):S13 http://www.infectagentscancer.com/content/4/S1/S13
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culating leptin levels were 43.1 ± 35.6 ng/ml, while the
heterozygous (GA) and homozygous (AA) variants had
mean leptin levels of 44.9 ± 32.2 ng/ml and 44.4 ± 28.7
ng/ml, respectively. These mean plasma leptin levels were
not statistically significantly different from each other
(adjusted p > 0.1). There were no statistically significant
differences in mean leptin levels across the LEPRQ223R
genotype variants among pre-menopausal African-Carib-
bean women (GG: 41.5 ± 31 ng/ml, GA: 42.9 ± 26.9 ng/
ml, AA: 39.1 ± 28.0 ng/ml, adjusted p > 0.1). In post-men-
opausal women mean leptin levels were higher for the
variant genotypes, but they were not statistically signifi-
cantly different (GG: 47.5 ± 49.4 ng/ml, GA: 50.9 ± 44.3
ng/ml, AA: 53.7 ± 28.0 ng/ml, adjusted p > 0.1) (Figure 2).
Leptin levels were compared in post-menopausal African-
Caribbean women and post-menopausal Caucasian and
African-American women (Figure 2); in general, African-
Americans had higher leptin levels, while Caucasian
women had lower leptin levels. After adjusting for age and
BMI, post-menopausal Caucasian women carrying the
homozygous (AA) variant genotype had marginally statis-
tically significantly higher leptin levels than women with
the wild-type genotype (52.1 ± 45.4 ng/ml vs. 40.2 ± 32.9
ng/ml, adjusted p = 0.056). There was no statistically sig-
nificant difference in leptin levels between Caucasian sub-
jects with the heterozygous and wild-type variants
(adjusted p > 0.1). Although higher leptin levels were
observed among African Americans there was no statisti-
cally significant difference observed when stratified by
genotype; however, there were only 19 African-American
subjects (adjusted p > 0.1).
Discussion
To our knowledge, we have for the first time described the
frequency of the LEPR Q223R variant in healthy popula-
tions of various ethnic groups. We have also compared the
genotype frequency in a subset of female subjects with
their mean circulating leptin levels. We observe statisti-
cally significant differences in genotype frequency and
mean circulating leptin levels based on ethnicity. African-
Caribbean and African-American subjects had higher fre-
quencies of the AA homozygous variant compared to Cau-
casian and African subjects. Since ethnicity was self-
reported, it is difficult to evaluate the degree and type of
admixture present in the populations of African descent
(African-American and African-Caribbean). The analysis
of the available African populations present in our study
indicates that there is a great variability in the LEPR
homozygous variant frequency in Africa, with Nigerian
subjects having a higher frequency (21%) than subjects
from Mali (12%). It is possible that the geographic areas
from which the African populations were taken during the
slave trades could influence the variations in the LEPR
gene frequency in populations of African descent. For
example, historical data seem to indicate that a higher
proportion of slaves were taken to the US and Caribbean
from Nigeria rather than Mali [31].
Among post-menopausal women, we observed significant
differences in the mean plasma leptin levels between Cau-
casians (42.4 ng/ml) and subjects of African Ancestry
(African-Americans: 61.1 ng/ml, African-Caribbeans: 51.7
ng/ml). These observed differences may be partly due to
differences in overall body mass index in these popula-
tions [32]. In our study, average BMI in African-American
post-menopausal women was statistically significantly
higher than BMI in Caucasians (data not shown). The role
of BMI in determining the differences in leptin levels
Mean circulating leptin levels according to LEPR Q223R geno- type in African-Caribbean women Figure 1
Mean circulating leptin levels according to LEPR Q223R geno-
type in African-Caribbean women.
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Table 2: Mean circulating leptin levels according to ethnicity and menopausal status.
Mean plasma Leptin levels ± SD
Race/Ethnicity Pre-menopausal N Post-menopausal N p-value
African-American (N = 19) - - 61.1 ng/ml ± 26.7 19 0.074*
African-Caribbean (N = 191) 41.8 ng/ml ± 27.8 135 51.7 ng/ml ± 38.2 56 0.039**
Caucasian (N = 340) - - 42.4 ng/ml ± 34.8 340
Asian/Other (N = 24) 37.9 ng/ml ± 30.4 14 31.6 ng/ml ± 20.0 10 0.427*
The p-values presented are for post-menopausal women, calculated with Caucasians as the reference group and *adjusted for body mass index and 
age; **adjusted for age only (BMI was not available fore these subjects). SD = standard deviation, N = number.Infectious Agents and Cancer 2009, 4(Suppl 1):S13 http://www.infectagentscancer.com/content/4/S1/S13
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between Caucasian women and African-Caribbean
women since BMI data was not available. However, for
the comparison between African-American and Caucasian
women, we were able to adjust the analysis for both age
and BMI, and still observed a significant difference in lep-
tin levels between the two ethnic groups, which could be
due to other environmental factors such as diet [33-35], or
by differences in genetic factors regulating leptin levels
[36].
In regards to this study, we were able to look at the influ-
ence of one main genetic polymorphism, LEPR, on circu-
lating leptin levels. For all three ethnic groups, leptin
levels were higher with the presence of the LEPR polymor-
phism, although the difference was not statistically signif-
icant. This seems to indicate that the functional
significance of the polymorphism is similar across the
three ethnic groups [15].
The strength of the present study is the availability of both
genetic information and leptin levels in healthy popula-
tions of both African origin and African descent; the main
limitations are: the modest number of African-American
and Asian subjects, the lack of pre-menopausal women
for some ethnic groups. A larger study on healthy subjects,
with complete epidemiological information, and with
genetic data on admixture is warranted. Simultaneous
testing of multiple genetic polymorphisms in addition to
the one currently studied is also desirable.
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